Transfer of omega‐3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid‐rich omega‐3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study
Journal of Internal Medicine2013Vol. 275(4), pp. 428–436
Citations Over TimeTop 10% of 2013 papers
Yvonne Freund‐Levi, Inger Vedin, Tommy Cederholm, Hans Basun, Gerd Faxén Irving, Maria Eriksdotter, Erik Hjorth, Marianne Schultzberg, B. Vessby, Lars‐Olof Wahlund, N. Salem, Jan Palmblad
Abstract
Oral supplementation with n-3 FAs conferred changes in the n-3 FA profile in CSF, suggesting transfer of these FAs across the BBB in adults.
Related Papers
- → Physiological Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)—A Review(2006)174 cited
- → Recent advances in functional analysis of polyunsaturated fatty acid synthases(2020)26 cited
- → Characteristic presence of polyunsaturated fatty acids in marine psychrophilic vibrios(1995)58 cited
- New Zealand women have suboptimal intakes of long chain omega-3 polyunsaturated fatty acids during pregnancy-a cross sectional study.(2017)
- → Rapeseeds a Rich Source of Polyunsaturated Fatty Acids(2019)